GE HealthCare Technologies Inc. logo
GEHCGE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. (GEHC) paid $0.14 in dividends per share over the trailing twelve months.

GEHC Annual Dividends per Share (Dividend History)

This step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency (typically quarterly or semi-annually).

Annual Dividend History List

Payment DateNominal Dividend / ShareDistribution Change
Apr 2, 2026$0.04
Jan 9, 2026$0.04
Oct 24, 2025$0.04
Jul 25, 2025$0.04
Apr 25, 2025$0.04
Jan 14, 2025$0.04+16.67% Hike
Oct 18, 2024$0.03
Jul 19, 2024$0.03
Apr 18, 2024$0.03
Jan 12, 2024$0.03
Oct 19, 2023$0.03
Jul 20, 2023$0.03
May 22, 2023$0.03

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Chicago, IL
53,000 employees
Healthcare / Medical - Healthcare Information Services
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Peter J. Arduini